Clinical Trial Update: Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Xueshuantong in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Xueshuantong

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Acute Ischemic Stroke | Phase 4 | Status: UNKNOWN